Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?

被引：3

作者：

Balsa, Alejandro ^{[1
]}

Garcia-Arias, Miriam ^{[1
]}

机构：

[1] Hosp Univ La Paz, IdiPAZ, Rheumatol Unit, Paseo Castellana,261, Madrid 28046, Spain

来源：

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE | 2010年 / 2卷 / 06期

关键词：

D O I：

10.1177/1759720X10384434

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：307 / 313

页数：7

共 52 条

[1]

Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO

[2]

2-9

[3] Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility [J].

Bakker, M. F. ;

Jacobs, J. W. G. ;

Verstappen, S. M. M. ;

Bijlsma, J. W. J. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 :56-60

[4] Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms [J].

Balsa, Alejandro ;

del Amo, Jokin ;

Blanco, Francisco ;

Caliz, Rafael ;

Silva, Lucia ;

Sanmarti, Raimon ;

Martinez, Francisco G. ;

Tejedor, Diego ;

Artieda, Marta ;

Pascual-Salcedo, Dora ;

Oreiro, Natividad ;

Collado, Maria D. ;

Andreu, Jose L. ;

Graell, Eduard ;

Simon, Laureano ;

Martinez, Antonio ;

Mulero, Juan .

RHEUMATOLOGY, 2010, 49 (03) :458-466

[5] Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].

Boers, M ;

Verhoeven, AC ;

Markusse, HM ;

vandeLaar, MAFJ ;

Westhovens, R ;

vanDenderen, JC ;

vanZeben, D ;

Dijkmans, BAC ;

Peeters, AJ ;

Jacobs, P ;

vandenBrink, HR ;

Schouten, HJA ;

vanderHeijde, DMFM ;

Boonen, A ;

vanderLinden, S .

LANCET, 1997, 350 (9074) :309-318

[6] Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed? [J].

Boers, Maarten .

ANNALS OF INTERNAL MEDICINE, 2009, 151 (09) :668-669

[7] Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial [J].

Bos, W. H. ;

Dijkmans, B. A. C. ;

Boers, M. ;

van de Stadt, R. J. ;

van Schaardenburg, D. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) :571-574

[8] Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis [J].

Braun, J. ;

Kaestner, P. ;

Flaxenberg, P. ;

Waehrisch, J. ;

Hanke, P. ;

Demary, W. ;

von Hinueber, U. ;

Rockwitz, K. ;

Heitz, W. ;

Pichlmeier, U. ;

Guimbal-Schmolck, C. ;

Brandt, A. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (01) :73-81

[9] An update on methotrexate [J].

Braun, Juergen ;

Rau, Rolf .

CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (03) :216-223

[10] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

← 1 2 3 4 5 6 →